Improving the Methodologic and Ethical Validity of Best Supportive Care Studies in Oncology: Lessons From a Systematic Review

被引:39
作者
Cherny, Nathan I. [1 ]
Abernethy, Amy P.
Strasser, Florian
Sapir, Rama
Currow, David
Zafar, S. Yousuf
机构
[1] Shaare Zedek Med Ctr, Dept Med Oncol, Canc Pain & Palliat Med Serv, Canc Pain & Palliat Med Unit, IL-91031 Jerusalem, Israel
关键词
CELL LUNG-CANCER; QUALITY-OF-LIFE; EVIDENCE-BASED RECOMMENDATIONS; METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; INTERLEUKIN-2 PLUS MELATONIN; PROSPECTIVE RANDOMIZED-TRIAL; PREVIOUSLY TREATED PATIENTS; PINEAL HORMONE MELATONIN; PALLIATIVE CARE;
D O I
10.1200/JCO.2009.21.9592
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To systematically review the best supportive care (BSC) literature and to evaluate the ethical and methodologic validity issues by using widely acknowledged criteria. Methods Two search strings that included both cancer and supportive as terms (with random article type, or review or meta-analysis) explored databases from 1966 to 2008. Citations, abstracts, and papers were reviewed for inclusion criteria, and relevant data were extracted by two independent researchers. Data were validated for accuracy. Ethical and methodologic validity were evaluated by using the criteria derived from the Helsinki Requirements of the WMA; CONSORT statements for the evaluation of reports of randomized, controlled trials; and the universal requirements for ethical clinical research. Results Forty-three published papers were identified that described 32 studies, 20 of which incorporated the design of treatment plus supportive care (SC) versus SC alone, and 12 of which incorporated the design of treatment versus SC. Most of the studies had poor compliance to critical Helsinki requirements, to methodologic precautions derived from the CONSORT statement for studies involving a nonpharmacologic arm, and to four of seven universal requirements for ethical clinical research. Conclusion Lack of rigor in BSC studies has contributed to a generation of research with widespread ethical and methodologic shortcomings. Ad hoc SC and lack of standardization of SC delivery may be sources of systematic bias or error in BSC trials. Rectifying these shortcomings in future studies demands greater vigilance toward these issues by researchers, institutional review boards, editors, and peer reviewers. Given the prevalence of overlooked problems that are later identified, currently open BSC studies should be reevaluated by institutional review boards and researchers to check for ethical and methodologic validity, and identified shortcomings should be addressed.
引用
收藏
页码:5476 / 5486
页数:11
相关论文
共 136 条
  • [1] Agrawal Manish, 2002, J Palliat Med, V5, P729, DOI 10.1089/109662102320880552
  • [2] AHMED N, 2004, COCHRANE DB SYST REV, V2
  • [3] Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474
  • [4] The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
    Altman, DG
    Schulz, KF
    Moher, D
    Egger, M
    Davidoff, F
    Elbourne, D
    Gotzsche, PC
    Lang, T
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) : 663 - 694
  • [5] Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
    Amado, Rafael G.
    Wolf, Michael
    Peeters, Marc
    Van Cutsem, Eric
    Siena, Salvatore
    Freeman, Daniel J.
    Juan, Todd
    Sikorski, Robert
    Suggs, Sid
    Radinsky, Robert
    Patterson, Scott D.
    Chang, David D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1626 - 1634
  • [6] Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome
    Anderson, H.
    Hopwood, P.
    Stephens, R. J.
    Thatcher, N.
    Cottier, B.
    Nicholson, M.
    Milroy, R.
    Maughan, T. S.
    Falk, S. J.
    Bond, M. G.
    Burt, P. A.
    Connolly, C. K.
    McIllmurray, M. B.
    Carmichael, J.
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 447 - 453
  • [7] [Anonymous], 2008, 59 WORLD MED ASS GEN
  • [8] [Anonymous], 1990, Cancer pain relief and palliative care: report of a WHO expert committee [meeting held in Geneva from 3 to 10 July 1989]
  • [9] [Anonymous], 2005, STAND PROV QUAL PALL
  • [10] BARNI S, 1995, ONCOLOGY, V52, P243